These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 25760073)
1. Elevated S100A6 (Calcyclin) enhances tumorigenesis and suppresses CXCL14-induced apoptosis in clear cell renal cell carcinoma. Lyu XJ; Li HZ; Ma X; Li XT; Gao Y; Ni D; Shen DL; Gu LY; Wang BJ; Zhang Y; Zhang X Oncotarget; 2015 Mar; 6(9):6656-69. PubMed ID: 25760073 [TBL] [Abstract][Full Text] [Related]
2. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma. Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway. Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913 [TBL] [Abstract][Full Text] [Related]
4. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma. Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221 [TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma. Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778 [TBL] [Abstract][Full Text] [Related]
6. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation. Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887 [TBL] [Abstract][Full Text] [Related]
7. The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma. Wang J; Zhang P; Zhong J; Tan M; Ge J; Tao L; Li Y; Zhu Y; Wu L; Qiu J; Tong X Oncotarget; 2016 May; 7(19):27142-57. PubMed ID: 27049827 [TBL] [Abstract][Full Text] [Related]
8. YAP is overexpressed in clear cell renal cell carcinoma and its knockdown reduces cell proliferation and induces cell cycle arrest and apoptosis. Cao JJ; Zhao XM; Wang DL; Chen KH; Sheng X; Li WB; Li MC; Liu WJ; He J Oncol Rep; 2014 Oct; 32(4):1594-600. PubMed ID: 25175178 [TBL] [Abstract][Full Text] [Related]
9. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression. Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573 [TBL] [Abstract][Full Text] [Related]
10. miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma. Lu GJ; Dong YQ; Zhang QM; Di WY; Jiao LY; Gao QZ; Zhang CG Int J Clin Exp Pathol; 2015; 8(5):5224-9. PubMed ID: 26191221 [TBL] [Abstract][Full Text] [Related]
11. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma. Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma. Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976 [TBL] [Abstract][Full Text] [Related]
13. RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma. Chen W; Niu S; Ma X; Zhang P; Gao Y; Fan Y; Pang H; Gong H; Shen D; Gu L; Zhang Y; Zhang X PLoS One; 2016; 11(7):e0157599. PubMed ID: 27384222 [TBL] [Abstract][Full Text] [Related]
14. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor. Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177 [TBL] [Abstract][Full Text] [Related]
15. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis. Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186 [TBL] [Abstract][Full Text] [Related]
16. Clear cell renal cell carcinoma induces fibroblast-mediated production of stromal periostin. Bakhtyar N; Wong N; Kapoor A; Cutz JC; Hill B; Ghert M; Tang D Eur J Cancer; 2013 Nov; 49(16):3537-46. PubMed ID: 23896380 [TBL] [Abstract][Full Text] [Related]
17. S100A6 Regulates Endothelial Cell Cycle Progression by Attenuating Antiproliferative Signal Transducers and Activators of Transcription 1 Signaling. Lerchenmüller C; Heißenberg J; Damilano F; Bezzeridis VJ; Krämer I; Bochaton-Piallat ML; Hirschberg K; Busch M; Katus HA; Peppel K; Rosenzweig A; Busch H; Boerries M; Most P Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1854-67. PubMed ID: 27386938 [TBL] [Abstract][Full Text] [Related]
18. miR-206 functions as a novel cell cycle regulator and tumor suppressor in clear-cell renal cell carcinoma. Xiao H; Xiao W; Cao J; Li H; Guan W; Guo X; Chen K; Zheng T; Ye Z; Wang J; Xu H Cancer Lett; 2016 Apr; 374(1):107-116. PubMed ID: 26808577 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of OCLN and GAS1 in clear cell renal cell carcinoma. Conceição AL; Da Silva CT; Badial RM; Valsechi MC; Stuqui B; Gonçalves JD; Jasiulionis MG; De Freitas Calmon M; Rahal P Oncol Rep; 2017 Mar; 37(3):1487-1496. PubMed ID: 28184927 [TBL] [Abstract][Full Text] [Related]
20. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma. Liu S; Ma X; Ai Q; Huang Q; Shi T; Zhu M; Wang B; Zhang X Urol Oncol; 2013 Aug; 31(6):938-48. PubMed ID: 21993533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]